Latest News for BORAY
Bora Pharmaceuticals Co., Ltd. (BORAY) Q2 2026 Earnings Call Transcript
MAPLE GROVE, Minn.--(BUSINESS WIRE)--Bora Pharmaceuticals and Onconic Therapeutics Sign Manufacturing Agreement to Support U.S. Clinical Development of JAQBO Tablets.
Taiwan-based contract drugmaker Bora Pharmaceuticals will partner with Insilico Medicine on a collaboration aimed at improving efficiency, potentially valued at more than $2.5 billion if fully implemented, the drug discovery firm said on Wednesday.
Combines Insilico's Pharma.AI platform with Bora's global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model CAMBRIDGE, Mass. and TAIPEI, July 14, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a multi-target strategic…
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for BORAY.
Senate Trading
No Senate trades found for BORAY.
U.S. House Trading
No House trades found for BORAY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.